北京以岭生物工程技术有限公司

Beijing Yiling Bioengineering Technology is a specialized biotechnology subsidiary of the Shijiazhuang Yiling Pharmaceutical Group, focused on the research and development of innovative biologics. Located in the Daxing Bio-Medicine Industry Park in Beijing, the company serves as a core innovation hub for the group, emphasizing the development of monoclonal antibodies and recombinant fusion proteins. Its pipeline primarily targets high-unmet-need areas in oncology, immunology, and cardiovascular health. The company integrates early-stage drug discovery with pilot-scale GMP manufacturing capabilities to accelerate the clinical transition of its therapeutic candidates.